DECISION: Revolutionising liver disease treatment for improved patient outcomes
The DECISION project, an EU-funded research initiative, is making significant strides in understanding the complex dynamics of acute decompensation of cirrhosis and its progression to acute-on-chronic liver failure (ACLF). In a recent…
The European Union launches the THRIVE project to improve the prognosis of children and adults with liver cancer
Endowed with €12 million, the project is coordinated by Josep M. Llovet, the head of the IDIBAPS group Translational Research in Hepatic Oncology, a professor of Medicine at the University of Barcelona…
Tribute to Sir Roy Calne (1930-2024)
It is with deep sorrow that EASL announces the passing of Sir Roy Calne, a pioneer in the field of transplantation. Sir Calne, a distinguished professor of surgery at Cambridge University, passed…
Public Health Community United Against Alcohol-Related Harm in the SANT Report on Non-Communicable Diseases
Press Release Brussels, 12 December 2023 As the European Parliament prepares for the vote on the Subcommittee on Health (SANT)’s Non-Communicable Diseases (NCDs) report, leading health organisations across the EU are actively…
People with cirrhosis and who receive a liver transplant are more susceptible to COVID-19 breakthrough infection
Study finds people with chronic liver disease and post-liver transplantation are at higher risk of getting infected with SARS-CoV-2 after COVID-19 primary series vaccination and identifies predictive factors associated with breakthrough infection.…
Liver Cancer Awareness Month – October 2023
Every October, we stand united for #LiverCancerAwarenessMonth, and EASL is proud to support this vital campaign. This month is a significant opportunity to raise awareness, educate, and advocate for liver health on…